Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal
- PMID: 22234313
- DOI: 10.1160/TH11-11-0773
Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal
Comment on
-
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.Thromb Haemost. 2011 Sep;106(3):429-38. doi: 10.1160/TH11-01-0052. Epub 2011 Jul 28. Thromb Haemost. 2011. PMID: 21800002
Similar articles
-
Prothrombin complex concentrates for reversal of vitamin K antagonists: assessing the risks.Thromb Haemost. 2011 Sep;106(3):389-90. doi: 10.1160/TH11-08-0521. Epub 2011 Aug 11. Thromb Haemost. 2011. PMID: 21833456 No abstract available.
-
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.Thromb Haemost. 2011 Sep;106(3):429-38. doi: 10.1160/TH11-01-0052. Epub 2011 Jul 28. Thromb Haemost. 2011. PMID: 21800002
-
Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury.Blood. 2011 Aug 18;118(7):1943-51. doi: 10.1182/blood-2011-03-343046. Epub 2011 Jun 13. Blood. 2011. PMID: 21670472
-
Cancer and thrombosis.Clin Adv Hematol Oncol. 2003 Nov;1(11):668-71. Clin Adv Hematol Oncol. 2003. PMID: 16258468 Review.
-
[Disseminated intravascular coagulation].Harefuah. 1972 Jul 2;83(1):29-32. Harefuah. 1972. PMID: 4264530 Review. Hebrew. No abstract available.
Cited by
-
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.Neurocrit Care. 2016 Feb;24(1):6-46. doi: 10.1007/s12028-015-0222-x. Neurocrit Care. 2016. PMID: 26714677 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources